Skip to main content

Table 3 Initial and maximum PCT levels, morbidity and mortality according to the type of pneumonia

From: Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study

  CAP N= 57 HAP N= 57 VAP N= 61 Overall P P (CAP versus HAP) P(CAP versus VAP)
Initial PCT (ng/ml) 2.4
(1.0, 15.8)
2.2
(0.4, 8.0)
0.7
(0.3, 2.15)
n.s n.s. < 0.001
Max. PCT (ng/ml) 5.3
(1.7, 17.7)
2.8
(0.4, 8.2)
1.0
(0.5, 3.4)
n.s. 0.021 < 0.001
Day of max. PCT 2
(1, 3)
1
(1, 2)
2
(1, 6)
< 0.001 0.012 n.s.
Maximum SOFA 9.5 ± 4.2 7.6 ± 3.8 6.7 ± 3.7 < 0.001 0.007 < 0.001
ICU length of stay (days) 13.0
(8.0, 17.5)
12.0
(7.0, 22.5)
26
(18, 43)
< 0.001 n.s. < 0.001
28 days mortality n (%) 21 (36.8%) 6 (10.5%) 5 (8.2%) < 0.001 0.002 < 0.001
  1. Continuous data are given as median (interquartile range) or mean ± standard deviation. CAP, community acquired pneumonia; HAP, hospital acquired pneumonia; ICU, intensive care unit; PCT, procalcitonin; n.s., not significant; SOFA, sequential organ failure assessment; VAP, ventilator associated pneumonia.